Manufacturing checks and balances give kaleo Inc. great confidence in the reliability of its Auvi-Q epinephrine auto-injector, which it plans to relaunch in the US on Feb. 14 after reacquiring rights from Sanofi and retooling production.
Auvi-Q is coming back on the market with some fanfare – the exact opposite of the way it limped off....



